Medicare Part D coverage of anti-obesity medications — challenges and uncertainty ahead

New England Journal of Medicine

11 March 2023 - Obesity is highly prevalent in the United States — affecting more than 41% of adults, including a similar percentage of older adults — and is linked to myriad health problems, such as type 2 diabetes, cardiovascular diseases, arthritic conditions, and some cancers. 

Obesity is associated with at least $174 billion in annual excess health care spending, with the highest excess expenditures occurring once people reach their 60s (approximately $1,500 to $3,000 per person annually).

Read New England Journal of Medicine Perspective

Michael Wonder

Posted by:

Michael Wonder

Posted in:

US , Medicare , Funding